The vagus nerve and the inflammatory reflex: Wandering on a new treatment paradigm for systemic inflammation and sepsis

Surgical Infections

Volumn 13, Issue 4, 2012, Pages 187-193

  Huston, Jared M ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; C REACTIVE PROTEIN; DROTRECOGIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE 2; STAT3 PROTEIN; THROMBIN; TUMOR NECROSIS FACTOR;

CENTRAL NERVOUS SYSTEM; CHOLINERGIC STIMULATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE SEVERITY; HEART RATE VARIABILITY; HUMAN; IMMUNE SYSTEM; INFECTION; INFLAMMATORY DISEASE; INNATE IMMUNITY; LEUKOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; REFLEX; SEPSIS; SHOCK; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE INJURY; VAGOTOMY; VAGUS NERVE; VAGUS NERVE MEDIATED INFLAMMATORY REFLEX;

ANIMALS; HUMANS; INFLAMMATION; NEUROIMMUNOMODULATION; REFLEX; SEPSIS; VAGUS NERVE;

EID: 84866976123     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2012.126     Document Type: Conference Paper

References (96)

1. Chinen J, Shearer WT. Advances in basic and clinical immunology in 2010. J Allergy Clin Immunol 2011;127:336-341.
2. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154:617-624. (Pubitemid 26327281)
3. Tracey KJ. Fatal Sequence: The killer within. Washington, DC. Dana Press. 2005:1-238.
4. Nathan C. Points of control in inflammation. Nature 2002; 420:846-852. (Pubitemid 36019637)
5. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab 1946;6:117-230.
6. Lowry SF. The evolution of an inflammatory response. Surg Infect 2009;10:419-425.
7. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-859. (Pubitemid 36019638)
8. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117:289-296. (Pubitemid 46203953)
9. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009;9:418-428.
10. Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000;85:1-17.
11. Watkins LR, Wiertelak EP, Goehler LE, et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res 1994;639:283-299. (Pubitemid 24078567)
12. Watkins LR, Wiertelak EP, Goehler LE, et al. Characterization of cytokine-induced hyperalgesia. Brain Res 1994;654: 15-26. (Pubitemid 24259397)
13. Hansen MK, O'Connor KA, Goehler LE, et al. The contribution of the vagus nerve in interleukin-1b-induced fever is dependent on dose. Am J Physiol Regul Integ Comp Physiol 2001;280:R929-R934.
14. Maier SF, Goehler LE, Fleshner M, et al. The role of the vagus nerve in cytokine-to-brain communication. Ann NY Acad Sci 1998;840:289-300. (Pubitemid 28302056)
15. Fairchild KD, Srinivasan V, Moorman JR, et al. Pathogen-induced heart rate changes associated with cholinergic nervous system activation. Am J Physiol Regul Integr Comp Physiol 2011;300:R330-R339.
16. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462. (Pubitemid 30367422)
17. Borovikova LV, Ivanova S, Nardi D, et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000;85:141-147.
18. Bernik TR, Friedman SG, Ochani M, et al. Cholinergic anti-inflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002;36:1231-1236. (Pubitemid 36236348)
19. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-788. (Pubitemid 34259722)
20. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388. (Pubitemid 36157937)
21. Yoshikawa H, Kurokawa M, Ozaki N, et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kb phosphorylation and nuclear factor-kb transcriptional activity through nicotinic acetylcholine receptor a7. Clin Exp Immunol 2006;146:116-123. (Pubitemid 44393846)
22. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6:844-851. (Pubitemid 43090471)
23. Boland C, Collet V, Laterre E, et al. Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats. Inflammation 2011;34:29-35.
24. Su X, Matthay MA, Malik AB. Requisite role of the cholin-ergic a7 nAChR pathway in suppressing gram-negative sepsis-induced acute lung injury inflammatory injury. J Immunol 2010;184:401-410.
25. dos Santos CC, Shan Y, Akram A, et al. Neuroimmune regulation of ventilator-induced lung injury. Am J Respir Crit Care Med 2011;183:471-482.
26. van Maanen MA, Lebre MC, van der Poll T, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009;60:114-122.
27. Song XM, Li JG, Wang YL, et al. Effect of vagus nerve stimulation on thermal injury in rats. Burns 2010;36:75-81.
28. Constantini TW, Bansal V, Peterson CY, et al. Efferent vagal nerve stimulation attenuates gut barrier injury after burn: Modulation of intestinal occludin expression. J Trauma 2010;68:1349-1356.
29. Ay I, Lu J, Ay H, et al. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett 2009;459:147-151.
30. Meregnani, J, Clarencon, D, Vivier M, et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 2011;160:82-89.
31. Nizri E, Irony-Tur-Sinai M, Lory O, et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 2009;183:6681-6688.
32. Guarini S, Cainazzo MM, Giuliani D, et al. Adrenocortico-tropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004;63:357-365. (Pubitemid 38900850)
33. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-kb activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107:1189-1194. (Pubitemid 36297213)
34. Lee ST, Chu K, Jung KH, et al. Cholinergic anti-inflammatory pathway in intracerebral hemorrhage. Brain Res 2010;1309: 164-171.
35. Mioni C, Bazzani C, Giuliani D, et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 2005;33:2621-2628. (Pubitemid 41682117)
36. Yeboah MM, Xue X, Ochani M, et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 2008;74:62-69. (Pubitemid 351841900)
37. Altavilla D, Guarini S, Bitto A, et al. Activation of the cho-linergic anti-inflammatory pathway reduces NF-kb activation, blunts TNF-a production, and protects against splanchnic artery occlusion shock. Shock 2006;25:500-506.
38. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimenal pancreatitis severity in mice. Gastroenterology 2006;130:1822-1830.
39. Wu R, Dong W, Cui X, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007;245:480-486. (Pubitemid 46673145)
40. Song XM, Li JG, Wang YL, et al. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 2008;30:468-472.
41. van Westerloo DJ, Giebelen IAJ, Florquin S, et al. The cho-linergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005;191: 2138-2148. (Pubitemid 40800586)
42. The FO, Boeckxstaens GE, Snoek SA, et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007;133:1219-1228. (Pubitemid 47494458)
43. Pavlov VA, Ochani M, Yang LH, et al. Selective a7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007; 35:1139-1144. (Pubitemid 46598966)
44. Hofer S, Eisenbach C, Lukic IK, et al. Pharmacologic choli-nesteraes inhibition improves survival in experimental sepsis. Crit Care Med 2008;36:404-408. (Pubitemid 351158611)
45. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004;10:1216-1221. (Pubitemid 39540438)
46. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Trans-cutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35:2762-2768. (Pubitemid 350175773)
47. Huston JM, Ochani M, Rosas-Ballina M, et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006;203:1623-1628.
48. Nance DM, Burns J. Innervation of the spleen in the rat: Evidence for absence of afferent innervation. Brain Behav Immun 1989;3:281-290.
49. Bellinger DL, Lorton D, Hamill RW, et al. Acetylcholines-terase staining and choline acetyltransferase activity in the young adult rat spleen: Lack of evidence for cholinergic in-nervation. Brain Beh Immun 1993;7:191-204. (Pubitemid 23302158)
50. Schafer MKH, Eiden LE, Weihe E. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter II: The peripheral nervous system. Neuroscience 1998;84:361-376. (Pubitemid 28122904)
51. Cano G, Sved AF, Rinaman L, et al. Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing. J Comp Neurol 2001;439:1-18.
52. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Beh Immun 2007;21:736-745.
53. Rosas-Ballina M, Ochani M, Parrish WR, et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105:11008-11013.
54. Kawashima K, Oohata H, Fujimoto K, et al. Extraneuronal localization of acetylcholine and its release upon nicotinic stimulation in rabbits. Neurosci Lett 1989;104:336-369.
55. Rinner I, Schauenstein K. Detection of choline-acetyl-transferase activity in lymphocytes. J Neurosci Res 1993;35: 188-291.
56. + T cell activity. Brain Beh Immun 2010;24:316-323.
57. O'Mahoney C, van der Kleij H, Bienenstock J, et al. Loss of vagal anti-inflammatory effect: In vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 2009;297:R1118-R1126.
58. Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcho-line- synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011;334:98-101.
59. Saeed RW, Varma S, Peng-Nemeroff T, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005;201:1113-1123. (Pubitemid 40524679)
60. Chatterjee PK, Al-Abed Y, Sherry B, et al. Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Cell Physiol 2009;297:C1294-C1206.
61. Huston JM, Rosas-Ballina M, Xue X, et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009;183:552-559.
62. Czura CJ, Schultz A, Kaipel M, et al. Vagus nerve stimulation regulates hemostasis in swine. Shock 2010;33:608-613.
63. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709. (Pubitemid 32204987)
64. Heider TR, Koruda MJ, Farrell TM, et al. Acute vagotomy does not augment the systemic inflammatory response in patients with peptic ulcer disease. Am Surg 2004;70:342-346.
65. Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G560-G567. (Pubitemid 47435388)
66. Ghia JE, Blennerhassett P, El-Sharkawy RT, et al. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G711-G718. (Pubitemid 47605929)
67. Daban C, Martinez-Aran A, Cruz N, et al. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression: A systematic review. J Affect Disord 2008;110:1-15.
68. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: A meta-analysis of efficacy and predictors of response. J Neurosurg 2011;Epub April 12.
69. DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41:1195-1200.
70. Barone L, Colicchio G, Policicchio D, et al. Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy. Neuroimmunomodulation 2007;14:331-336. (Pubitemid 351737861)
71. De Herdt V, Bogaert S, Bracke KR, et al. Effects of vagus nerve stimulation on pro-and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuro-immunol 2009;214:104-108.
72. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. Ann Surg 1992;216:172-183.
73. Deitch EA. Nutrition and the gut mucosal barrier. Curr Opin Gen Surg 1993;85-91.
74. Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 1988; 104:185-190.
75. Luyer MD, Greve JWM, Hadfoune M, et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005;202:1023-1029. (Pubitemid 41464495)
76. Lubbers T, De Haan JJ, Hadfoune M, et al. Lipid-enriched enteral nutrition controls the inflammatory response in mu-rine gram-negative sepsis. Crit Care Med 2010;38:1996-2002.
77. Tracey KJ. Fat meets the cholinergic antiinflammatory pathway. J Exp Med 2005;202:1017-1021.
78. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996;93: 1043-1065.
79. Gaziano EP, Freeman DW. Analysis of heart rate patterns preceding fetal death. Obstet Gynecol 1977;50:578-582. (Pubitemid 8223573)
80. Sampson MB, Mudaliar NA, Lele AS. Fetal heart rate variability as an indicator of fetal status. Postgrad Med 1980; 67:207-205.
81. Lauersen NH, Wilson KH, Bilek A, et al. A new modality in nonstress testing: Evaluation of beat-to-beat fetal heart rate variability. Am J Obstet Gynecol 1981;141:521-526. (Pubitemid 12228187)
82. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262. (Pubitemid 17036947)
83. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;351:478-484. (Pubitemid 28070094)
84. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992;85:177-191.
85. Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res 1993;3:5-13. (Pubitemid 23136536)
86. Schmidt H, Muller-Werdan U, Hoffmann T, et al. Auto-nomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 2005;33:1994-2002. (Pubitemid 41306521)
87. Aydemir M, Yazisiz V, Basarici I, et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythe-matosus. Lupus 2010;19:255-261.
88. Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 2007;16:181-185. (Pubitemid 46506595)
89. Sharma P, Makharia GK, Ahuja V, et al. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Dig Dis Sci 2009;54:853-861.
90. Lindgren S, Stewenius J, Sjolund K, et al. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993;28:638-642. (Pubitemid 23192697)
91. Pavlov VA, Ochani M, Gallowitsch-Puerta M, et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 2006;103:5219-5223.
92. Huston JM, Tracey KJ. The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011;269:45-53.
93. Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection: An update. Crit Care Med 1999;27:836-842. (Pubitemid 29218222)
94. McKinley BA, Moore LJ, Sucher JF, et al. Computer protocol facilitates evidence-based care of sepsis in the surgical intensive care unit. J Trauma 2011;70:1153-1167.
95. Shiramizo SCPL, Marra AR, Durao MS, et al. Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One 2011;6:e2679.
96. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med 2010;38:1036-1043.